Older patients with breast cancer: is there bias in the treatment they receive?
- 8 August 2012
- journal article
- Published by SAGE Publications in Therapeutic Advances in Medical Oncology
- Vol. 4 (6) , 321-327
Abstract
Breast cancer is the most frequent malignant tumor in women worldwide and as breast cancer incidence increases with increasing age, over 40% of new cases are diagnosed in women older than 65 years of age. However, older patients are not treated to the same extent as younger patients and increasing age at diagnosis predicts deviation from guidelines for all treatment modalities. Evidence-based medicine in older patients is lacking as they are usually excluded from clinical trials often because of existing comorbidities and limited life expectancy. Accordingly, there is a higher competing risk of death from other causes than breast cancer compared with younger patients and this may have led to the false interpretation that prognosis of breast cancer in older patients is relatively good. However, every treatment modality should be evaluated during treatment decision making. Multimodal therapy should not be routinely withheld as data show that disease-specific mortality increases with age, probably due to undertreatment. Prognostic markers, fitness and comorbidities rather than chronological age should determine optimal, individualized therapy. It is recommended that treatment decisions should be discussed in a multidisciplinary setting, ideally in combination with any form of geriatric assessment, to improve breast cancer outcome in the older population.Keywords
This publication has 41 references indexed in Scilit:
- Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trialsThe Lancet, 2012
- Age-Specific Nonpersistence of Endocrine Therapy in Postmenopausal Patients Diagnosed with Hormone Receptor–Positive Breast Cancer: A TEAM Study AnalysisThe Oncologist, 2011
- Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High‐Age Patients (CRASH) scoreCancer, 2011
- Adjuvant chemotherapy in older women (ACTION) study – what did we learn from the pilot phase?British Journal of Cancer, 2011
- The changing field of locoregional treatment for breast cancer.2011
- The Influence of Comorbidities on Overall Survival Among Older Women Diagnosed With Breast CancerJNCI: Journal of the National Cancer Institute, 2011
- Causes of Death and Relative Survival of Older Women After a Breast Cancer DiagnosisJournal of Clinical Oncology, 2011
- Compliance with breast‐conservation standards for patients with early‐stage breast carcinomaCancer, 2003
- Effect of Age and Comorbidity in Postmenopausal Breast Cancer Patients Aged 55 Years and OlderJAMA, 2001
- Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment TrialsNew England Journal of Medicine, 1999